TABLE 2.

Local adverse events experienced in the 5-day observation period following immunization of pediatric CF patients with the virosome or subunit influenza vaccine

Vaccine	Dose (ml)	Group (no. of subjects)	Mean age of subjects (yr)	Total no. (%) of vaccines with at least one adverse event	% of vaccines with:
					Pain	Induration	Redness	Swelling
Inflexal Berna V	0.5, once	A1 (4)	4.1	1	25	0	0	0
	0.5, once	A2 (15)	14.5	10 (67)	53	13	20	27
	0.25, twice	B1 (5)	3.8	0	0	0	0	0
	0.25, twice	B2 (19)	16.4	8 (42)	31	5.3	21	5.3
Influvac	0.25, twice	C (2)	2.9	1	50	0	0	0
	0.5, once	D (19)	15.7	11 (58)	53	21	21	21